CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
Boston, Massachusetts, United States and 83 other locations
This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....
Phase 2
Boston, Massachusetts, United States and 6 other locations
28-week Phase 3 Efficacy and Safety Study of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma...
Phase 3
Boston, Massachusetts, United States and 121 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Fall River, Massachusetts, United States and 122 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Boston, Massachusetts, United States and 115 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Boston, Massachusetts, United States and 6 other locations
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...
Phase 4
Warwick, Rhode Island, United States and 34 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Boston, Massachusetts, United States and 381 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Fall River, Massachusetts, United States and 318 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Boston, Massachusetts, United States and 419 other locations
Clinical trials
Research sites
Resources
Legal